Announcements Trials
Browse Landscape

Phase

Phase 3 12Phase 2 7Phase 2/3 4Phase 1 3Phase NA 2Phase 4 2

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1

Conditions

Fatigue 3Neoplasms 2Prostatic Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Methylphenidate × Clear all
NCT03772834 2026-05-04

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
188 enrolled

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT00424099 2023-06-01

Methylphenidate and a Nursing Telephone Intervention for Fatigue

M.D. Anderson Cancer Center

Phase 2/3 Completed
197 enrolled 10 charts

Fatigue

NCT00758407 2010-01-13

EMF

Medice Arzneimittel Pütter GmbH & Co KG

Phase 2/3 Completed
66 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡